Zhitong Finance App News, *ST Weiming (002581.SZ) announced that the company plans to transfer 100% of the company's shares in Jilin Weiming Tianren Chinese Herbal Medicine Technology Development Co., Ltd. (hereinafter referred to as “Jilin Weiming”), “recombinant anti-TNFα all-human monoclonal antibody injection” pharmaceutical technology, and “injectable recombinant anti-CD25 human mouse chimeric monoclonal antibody” pharmaceutical technology (hereinafter referred to as “two pharmaceutical technologies”). The transaction is based on historical costs, and the initial public listing transfer price is not lower than the historical cost.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.